New type-2 diabetes drug may target glucose production in liver

07 Sept 2015


A new study, led by Washington University School of Medicine in St. Louis and published in the journal Cell Metabolism, suggests that it is possible to treat type-2 diabetes by slowing the production of glucose in the liver.

Medical News Today


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story